Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Global Blood Therapeutics Inc. (GBT)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Casdin Capital

Eli Casdin

300,000 $15,780,000 1.57%
2.
Bailard Inc

Thomas Bailard

5,000 $243 -91% 0.01%
3.
Segantii Capital

Simon Sadler

0 $0 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$38.00 175,000 Large Shareholder 4,889,066 2017-12-19 Filing
$20.00 25,000 Officer 25,000 2015-08-17 Filing
$22.36 1,000 Officer 1,500 2016-01-07 Filing
$20.00 500 Officer 500 2015-08-17 Filing
$20.00 5,000 Director 26,428 2015-08-17 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$48.33 2,200 Officer 10,186 2019-11-01 Filing
$48.68 1,127 Officer 12,386 2019-11-01 Filing
$45.05 5,357 Director 0 2019-10-08 Filing
$48.70 3,249 Officer 13,513 2019-10-01 Filing
$54.36 2,765 Officer 887 2019-09-11 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 26,176 $1,270 0.9%
2. 235,762 $11,439 0.4%
3. 446,011 $21,640 0.11%
4. 16,487 $800 0.11%
5. 307,452 $14,918 0.1%